Completed OBSERVATIONAL NCT01609621

Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions

Sponsor: Cook Group Incorporated

Conditions Critical Limb Ischemia Peripheral Arterial Disease

Interventions Retrograde tibiopedal arterial access

Updated 9 times since 2017 Last updated: Nov 16, 2020 Started: May 31, 2012 Primary completion: Jul 31, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Critical Limb Ischemia and Peripheral Arterial Disease, this trial is completed. The trial is conducted by Cook Group Incorporated and has accumulated 9 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2020 — Jan 2021 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Dec 2020 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cook Group Incorporated

Data source: Cook Group Incorporated

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abano Terme, Italy , Bad Krozingen, Germany , Charleston, United States , Houma, United States , Jacksonville, United States , Leipzig, Germany , Miami, United States , Raleigh, United States , Tucson, United States , Washington D.C., United States and 1 more location